While the overall safety profile is favorable, no injectable treatment is entirely without risk, and patients deserve full disclosure before consenting to the procedure
The effectiveness of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists on cardiorenal outcomes: systematic review and meta- analysis
Patients with Type 2 diabetes who received GLP-1RAs had an increased risk of gastroparesis diagnosis at six, nine, 12, 18 and 24 months
Post-reconstitution: dark glass, light-blocking storage containers recommended
Since erections depend fundamentally on adequate blood flow to the penile tissues, any impairment in vascular function can compromise erectile capability
This is for informational purposes only